Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Apr 28, 2014
Clinical News

CTP-499: Phase II data

BioCentury | Feb 17, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Feb 14, 2014
Financial News

Concert raises $84 million in IPO

BioCentury | Feb 4, 2014
Financial News

Concert sets IPO terms

BioCentury | Jan 14, 2014
Financial News

Concert, Microlin Bio file for IPOs

BioCentury | Feb 25, 2013
Clinical News

CTP-499: Completed Phase II enrollment

BioCentury | Mar 12, 2012
Clinical News

CTP-499: Phase II started

BioCentury | Jan 2, 2012
Clinical News

CTP-499: Phase I data

BioCentury | Apr 4, 2011
Clinical News

CTP-499: Phase I started

Items per page:
1 - 10 of 10